How Blood Factors in Type 2 Diabetes May Accelerate Breast Cancer Progression
Research reveals how blood particles altered by type 2 diabetes can weaken immune responses within breast tumors, potentially increasing cancer aggression and spread. This discovery offers new insights into treating diabetic cancer patients more effectively.
Recent research from Boston University School of Medicine has uncovered a significant link between type 2 diabetes and increased breast cancer severity. The study reveals that specific particles in the blood, called exosomes, which are altered in individuals with diabetes, play a crucial role in modifying immune responses within tumors. These exosomes can reprogram immune cells, weakening their ability to combat cancer and thereby promoting tumor growth and spread.
This groundbreaking work is the first to establish a direct connection between diabetic exosomes and suppressed immune activity in human breast tumors. Using patient-derived organoids—3D tumor models containing the patient's original immune cells—researchers observed how blood exosomes from diabetic individuals influence tumor behavior. The organoids were treated with exosomes from both diabetic and non-diabetic blood samples, and single-cell RNA sequencing revealed that diabetic exosomes diminish immune cell effectiveness within the tumor microenvironment.
Dr. Gerald Denis, the lead researcher, emphasized that this discovery provides a potential explanation for why women with type 2 diabetes often experience poorer outcomes in breast cancer treatment. It also sheds light on why immunotherapies may be less effective in these patients. By understanding how diabetes impacts tumor immunity, clinicians can move toward developing more personalized and effective treatments for millions affected by both conditions.
Given that over 120 million Americans are prediabetic or diabetic, this research addresses a major public health concern. It highlights the importance of considering metabolic health in cancer management and suggests new avenues for improving treatment efficacy in diabetic cancer patients.
This study was published in Communications Biology and is available for further reference at source.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Medication Significantly Boosts Survival After First Heart Attack in Patients Over 90
New research reveals that guideline-directed medical therapy greatly increases survival rates after first heart attack, even in patients over 90 years old, emphasizing the importance of personalized treatment strategies for the elderly.
Combination of Diabetes Medication and Antihistamine Shows Promise in Repairing Multiple Sclerosis Damage
A groundbreaking clinical trial reveals that combining metformin and clemastine could help repair nerve damage in multiple sclerosis, potentially transforming future treatments. Researchers emphasize further studies for safety and efficacy.
Antibiotics During Pregnancy May Lower Risk of Preterm Births
A groundbreaking study indicates that daily use of safe antibiotics during pregnancy may significantly reduce preterm births, offering a new strategy to improve neonatal survival, especially in regions with high infection rates.
Enhanced COPD Care Pathway Shortens Hospital Stay and Boosts Pulmonary Rehab Referrals
Implementing a structured COPD care pathway can significantly reduce hospital stays and increase referrals to pulmonary rehabilitation, leading to better patient outcomes and more standardized care protocols.